US Stock MarketDetailed Quotes
NVCT Nuvectis Pharma
- 5.090
- +0.070+1.39%
Trading Dec 27 10:52 ET
98.34MMarket Cap-4.39P/E (TTM)
5.170High4.850Low63.28KVolume4.880Open5.020Pre Close319.89KTurnover0.88%Turnover RatioLossP/E (Static)19.32MShares12.10052wk High8.95P/B36.46MFloat Cap4.44052wk Low--Dividend TTM7.16MShs Float20.920Historical High--Div YieldTTM6.37%Amplitude3.080Historical Low5.055Avg Price1Lot Size
Nuvectis Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 25.89%-2.4M | 26.03%-3.02M | 8.77%-4.36M | -17.66%-15.95M | -9.50%-3.85M | 26.67%-3.24M | -60.56%-4.08M | -55.30%-4.78M | -42.67%-13.56M | -229.52%-3.52M |
| Net income from continuing operations | 29.38%-4.15M | 22.42%-4.43M | -3.01%-4.17M | -16.64%-22.26M | 1.11%-6.62M | -0.07%-5.88M | -59.93%-5.71M | -37.58%-4.05M | -48.06%-19.09M | -196.15%-6.7M |
| Change In working capital | -60.77%590K | -78.37%146K | 30.38%-1.48M | -58.08%1.6M | -42.48%1.55M | 68.23%1.5M | 30.81%675K | -637.02%-2.13M | 155.62%3.82M | 167.39%2.7M |
| -Change in payables and accrued expense | -60.03%546K | -71.74%78K | 28.30%-1.29M | -69.86%1.25M | -25.27%1.41M | -6.05%1.37M | 6.15%276K | -432.47%-1.8M | 161.20%4.14M | 71.27%1.88M |
| -Change in other current assets | -68.12%44K | -82.96%68K | 41.77%-191K | 209.97%353K | -82.31%144K | 124.64%138K | 55.86%399K | 60.53%-328K | -252.75%-321K | 994.51%814K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 25.89%-2.4M | 26.03%-3.02M | 8.77%-4.36M | -17.66%-15.95M | -9.50%-3.85M | 26.67%-3.24M | -60.56%-4.08M | -55.30%-4.78M | -42.67%-13.56M | -229.52%-3.52M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 107.25%1.46M | -87.35%1.67M | 1,763.49%4.7M | -45.75%15.09M | 800.00%917K | -95.15%703K | 2,386.33%13.22M | -98.20%252K | 82.41%27.81M | -131K |
| Net common stock issuance | 33.84%1.51M | -47.06%1.73M | --4.85M | -83.41%5.29M | --901K | -92.91%1.13M | --3.26M | --0 | --31.88M | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --11.19M | --0 | --14K | --10.48M | --702K | --0 | --0 |
| Net other financing activities | 88.56%-50K | 89.48%-55K | 66.00%-153K | 65.74%-1.39M | 112.21%16K | 68.49%-437K | 9.52%-523K | 77.19%-450K | ---4.07M | ---131K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 107.25%1.46M | -87.35%1.67M | 1,763.49%4.7M | -45.75%15.09M | 800.00%917K | -95.15%703K | 2,386.33%13.22M | -98.20%252K | 82.41%27.81M | ---131K |
| Net cash flow | ||||||||||
| Beginning cash position | -26.36%18.12M | 25.83%19.46M | -4.34%19.13M | 248.19%19.99M | -6.69%22.06M | 81.26%24.6M | -7.34%15.47M | 248.19%19.99M | --5.74M | 247.19%23.64M |
| Current changes in cash | 62.73%-947K | -114.76%-1.35M | 107.47%338K | -106.08%-867K | 19.58%-2.93M | -125.24%-2.54M | 392.60%9.13M | -141.32%-4.53M | 148.19%14.25M | -241.80%-3.65M |
| End cash Position | -22.17%17.17M | -26.36%18.12M | 25.83%19.46M | -4.34%19.13M | -4.34%19.13M | -6.69%22.06M | 81.26%24.6M | -7.34%15.47M | 248.19%19.99M | 248.19%19.99M |
| Free cash flow | 25.89%-2.4M | 26.03%-3.02M | 8.77%-4.36M | -17.66%-15.95M | -9.50%-3.85M | 26.67%-3.24M | -60.56%-4.08M | -55.30%-4.78M | -42.67%-13.56M | -229.52%-3.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data